Corbus Pharmaceuticals
CRBP
CRBP
101 hedge funds and large institutions have $164M invested in Corbus Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.29% less ownership
Funds ownership: 1.51% → 1.22% (-0.29%)
35% less call options, than puts
Call options by funds: $3.32M | Put options by funds: $5.08M
Holders
101
Holding in Top 10
1
Calls
$3.32M
Puts
$5.08M
Top Buyers
| 1 | +$6.42M | |
| 2 | +$4.44M | |
| 3 | +$3.87M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.69M |
| 5 |
SC
Sculptor Capital
New York
|
+$1.04M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$11.3M | |
| 3 | -$1.46M | |
| 4 |
BlackRock
New York
|
-$757K |
| 5 |
Millennium Management
New York
|
-$716K |